Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors (Q84922406)
Jump to navigation
Jump to search
scientific article published on 17 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors |
scientific article published on 17 November 2009 |
Statements
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors (English)
K Schultz
K Nilsson
J E Nielsen
S G Lindquist
L E Hjermind
B B Andersen
A Wallin
C Nilsson
17 November 2009